Landon Capital

Landon capital

Capital Market News, Capital Markets Now

MTC

2.21 USD

+ 626.97%
OPP^

0.0097 USD

+ 410.53%
GCMGW

0.1602 USD

+ 100.00%
SLDPW

2.16 USD

+ 83.05%
LMNX

40.0081 USD

+ 69.27%
NNNN

22.0 USD

+ 57.48%
GGROW

0.0244 USD

+ 53.46%
SLDP

8.51 USD

+ 51.56%
NXPLW

0.14 USD

+ 51.02%
EUDAW

0.12 USD

+ 49.63%
LEGT+

0.55 USD

+ 48.61%
DSYWW

0.0325 USD

+ 47.73%
RVNL

38.4026 USD

+ 46.36%
WHLRL

119.5 USD

+ 45.73%
SMXWW

0.031 USD

+ 45.54%
SMX

2.11 USD

+ 43.54%
EVC

2.835 USD

+ 43.18%
SONN

4.55 USD

+ 42.19%
XBPEW

0.05 USD

+ 41.64%
LNAI

1.17 USD

+ 40.29%

Top Gainer

Latest News

It’s a no for me, FDA rejects Biohaven’s (NYSE: BHVN) SCA treatment Biohaven (NYSE: BHVN) stock fell 44% after the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) for the company’s New Drug Application for VYGLXIA (troriluzole), rejecting its approval for spinocerebellar ataxia (SCA). The FDA cited concerns related to the real-world evidence study that formed the …